Watchlist

Watchlist
AMAG Pharmaceuticals, Inc. (AMAG)
AMAG Pharmaceuticals, Inc. (AMAG)
Premarket analyst action - healthcare
Cancer Genetics (NASDAQ: CGIX ) initiated with Buy rating and $6 (179% upside) price target by Maxim Group. More news on: Cancer Genetics, Inc., AMAG Pharmaceuticals, Inc., Celldex Therapeutics, Inc, Healthcare stocks news, Read more …
Your Daily Pharma Scoop: Valeant's B+L In India, TXMD's NDA Resubmission, Melinta Makes An Acquisition
This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Valeant B+L This is a tidy little art…
Palatin Technologies Announces Signing of Licensing Agreement with Kwangdong Pharmaceutical for Republic of Korea
CRANBURY, N.J. , Nov. 21, 2017 /PRNewswire/ --Palatin Technologies, Inc. (NYSE MKT: PTN; "Palatin") announced today that it has entered into a collaboration and license agreement with Kwangdong Pharmaceutical Co., Ltd. ("Kwangdong"), for exclusive rights to develop and commercialize…
Antares Pharma On Sale
Antares Pharma ( ATRS ) stock has experienced a severe drop in price since it received notification from the FDA that its testosterone drug Xyosted would not be approved in October, followed by a CRL one week later. From a recent high of $4.09 to a recent low of $1.58 (November 8), the stock h…
The Sum Of All Fears For This Small Pharma
It's been a wild ride for Antares Pharma ( ATRS ) investors over the past few months. As such, I'll do my best to provide a relatively comprehensive update on the company. As a little bit of warning to readers, I'm writing this article from the prospective that the reader is familiar with the …
AMAG Pharmaceuticals, Inc. 2017 Q3 - Results - Earnings Call Slides
The following slide deck was published by AMAG Pharmaceuticals, Inc. in conjunction with their 2017 Q3 earnings Read more …
AMAG Pharmaceuticals (AMAG) CEO Bill Heiden on Q3 2017 Results - Earnings Call Transcript
AMAG Pharmaceuticals, Inc. (AMAG) Q3 2017 Earnings Conference Call November 2, 2017 09:00 a.m. ET Executives Bill Heiden - President, Chief Executive Officer Nik Grund - Chief Commercial Officer Ted Myles - Chief Financial Officer Linda Lennox - Vice President, Investor Relatio…
Morgan Stanley defends AMAG Pharma after Q3 miss and softer guidance-stoked selloff; shares up 5%
AMAG Pharmaceuticals ( AMAG +4.9% ) is clawing back from yesterday's 20% high-volume plunge after it posted Q3 results that included a $13.6M revenue miss and downward revision to 2017 guidance. More news on: AMAG Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the m…
AMAG Pharmaceuticals misses by $4.49, misses on revenue
AMAG Pharmaceuticals (NASDAQ: AMAG ): Q3 EPS of -$4.31 misses by $4.49 . More news on: AMAG Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more …
Notable earnings before Thursday's open
AAON , ABC , ACIW , ADNT , ADP , AER , AES , AMAG , AMCX , AME , AN , ANIP , APA , APLP , ARCC , AROC , ARW , AVP , AYR , BABA , BCE , BDX , BIOS , BLL , BTE , CBB , CBZ , CCOI , CHD , CHK , CHSP , CI , CIM , CNNX , CNQ , CNSL , CRCM , CRK , CVE , CYB…
Magic Formula Investing Companies Vs. The Most Traded Companies In The U.S. Markets
Are you among all those people who wonder how strong the Magic Formula Companies actually are? What their financial status are compared to the most traded companies in the U.S. Markets for example? And not at least how they perform in the market compared to the most traded companies? A while a…
AMAG Pharmaceuticals, Inc. (AMAG)